Live Nasdaq Composite: Cautious Optimism Takes Hold as Chip Stocks Rebound and SpaceX IPO Nears

Investing

Pfizer : PFE

All Pfizer Articles

1486 Articles

Paul Ausick | Feb 16, 2018 at 4:01 PM EST

Pfizer, UnitedHealth Boost DJIA on Friday

Pfizer, UnitedHealth, Disney, and Johnson & Johnson lifted the DJIA on Friday.

Chris Lange | Feb 12, 2018 at 9:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Feb 8, 2018 at 8:15 AM EST

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety…

Jon C. Ogg | Jan 31, 2018 at 1:55 PM EST

10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News

These are the 10 stocks tracked by 24/7 Wall St. that received multiple analyst rating upgrades or price target hikes…

Jon C. Ogg | Jan 31, 2018 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot…

Paul Ausick | Jan 30, 2018 at 4:01 PM EST

UnitedHealth, Pfizer Tank the DJIA Tuesday

UnitedHealth, Pfizer, McDonald's, and General Electric put in a dismal day and led the DJIA to steep loss Tuesday.

Paul Ausick | Jan 30, 2018 at 7:55 AM EST

Pfizer Earnings, Guidance May Not Be Enough for Investors

Pharmaceuticals giant Pfizer beat quarterly and full-year expectations this morning, but the beats were small and the forecast for next…

Chris Lange | Jan 28, 2018 at 10:20 AM EST

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of Exxon, Apple, Pfizer and other the Dow Jones Industrial Average companies…

Paul Ausick | Jan 26, 2018 at 4:01 PM EST

Intel, Pfizer Drive DJIA Surge Higher on Friday

Intel, Pfizer, 3M, and Disney launched the DJIA to a solid gain Friday.

Chris Lange | Jan 25, 2018 at 10:10 AM EST

Major Pharma Short Interest Keeps Climbing

The January 12 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 17, 2018 at 4:15 PM EST

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Apple indicated that it will pay $38 billion in repatriation taxes under the new tax law. Apple says that it…

Chris Lange | Jan 11, 2018 at 9:45 AM EST

Major Pharma Short Interest Takes a Plunge

The December 29 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Jan 8, 2018 at 4:01 PM EST

UnitedHealth, Disney Weigh on DJIA Monday

UnitedHealth, Disney, Pfizer, and General Electric were Monday's laggards among the DJIA stocks.

Chris Lange | Jan 4, 2018 at 9:10 AM EST

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

For the Jones Industrial Average to make its 2018 targets, Pfizer and Merck will to have to do their part…

Chris Lange | Jan 3, 2018 at 10:45 AM EST

Sangamo Jumps on Newest Pfizer Collaboration

Sangamo Therapeutics shares made a handy gain on hump day after the firm announced that it would be collaborating with…

1 … 36 37 38 39 40 … 100

Pfizer : PFE

All Pfizer Articles

Pfizer, UnitedHealth Boost DJIA on Friday

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

UnitedHealth, Pfizer Tank the DJIA Tuesday

Pfizer Earnings, Guidance May Not Be Enough for Investors

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

Intel, Pfizer Drive DJIA Surge Higher on Friday

Major Pharma Short Interest Keeps Climbing

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Major Pharma Short Interest Takes a Plunge

UnitedHealth, Disney Weigh on DJIA Monday

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

Sangamo Jumps on Newest Pfizer Collaboration

Live Nasdaq Composite: Cautious Optimism Takes Hold as Chip Stocks Rebound and SpaceX IPO Nears

6 Months Later: Is Vanguard’s Overlooked Monthly Income ETF Still Worth It?

Why a $1.4 Million 401(k) Makes That Side Hustle Far More Expensive Than You Think

What a $1.5 Million Dividend Portfolio Actually Pays a Retired Couple After Federal Tax, State Tax, and IRMAA

Why a $1.4 Million 401(k) Makes That Side Hustle Far More Expensive Than You Think

What a $1.5 Million Dividend Portfolio Actually Pays a Retired Couple After Federal Tax, State Tax, and IRMAA

6 Months Later: Is Vanguard’s Overlooked Monthly Income ETF Still Worth It?

Why a $1.4 Million 401(k) Makes That Side Hustle Far More Expensive Than You Think

Pfizer : PFE

All Pfizer Articles

Pfizer, UnitedHealth Boost DJIA on Friday

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

10 Stocks Seeing Multiple Analyst Upgrades After Earnings and Key News

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

UnitedHealth, Pfizer Tank the DJIA Tuesday

Pfizer Earnings, Guidance May Not Be Enough for Investors

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

Intel, Pfizer Drive DJIA Surge Higher on Friday

Major Pharma Short Interest Keeps Climbing

Beyond Apple Repatriation: 16 US Corporate Giants Have $1 Trillion in Cash

Major Pharma Short Interest Takes a Plunge

UnitedHealth, Disney Weigh on DJIA Monday

2018 Bull/Bear Outlook Pfizer and Merck: Where Does Major Health Care Go From Here?

Sangamo Jumps on Newest Pfizer Collaboration

Live Nasdaq Composite: Cautious Optimism Takes Hold as Chip Stocks Rebound and SpaceX IPO Nears

6 Months Later: Is Vanguard’s Overlooked Monthly Income ETF Still Worth It?

Why a $1.4 Million 401(k) Makes That Side Hustle Far More Expensive Than You Think

What a $1.5 Million Dividend Portfolio Actually Pays a Retired Couple After Federal Tax, State Tax, and IRMAA

Featured Reads

Why a $1.4 Million 401(k) Makes That Side Hustle Far More Expensive Than You Think

What a $1.5 Million Dividend Portfolio Actually Pays a Retired Couple After Federal Tax, State Tax, and IRMAA